Efficacy and Safety of Mitoxantrone Use in Aggressive Multiple Sclerosis

被引：0
|
作者：
Fabis-Pedrini, Marzena J. [1 ]
Carroll, William M. [1 ,2 ]
Kermode, Allan G. [1 ,2 ,3 ]
机构：
[1] Perron Inst Neurol & Translat Sci, Perth, WA, Australia
[2] Sir Charles Gairdner Hosp, Perth, WA, Australia
[3] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.414
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: Experience in an Indian tertiary care setting
    Singhal, B. S.
    Geeta, Sheth
    Hundalani, Shilpa G.
    Menon, Suresh
    NEUROLOGY INDIA, 2009, 57 (04) : 418 - U184
  • [22] Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis
    Marco Capobianco
    Simona Malucchi
    Stefano Ulisciani
    Carmen Fava
    Giovanna Rege Cambrin
    Luigina Avonto
    Giuseppe Saglio
    Antonio Bertolotto
    Neurological Sciences, 2008, 29 : 185 - 187
  • [23] Rituximab vs. mitoxantrone: comparing efficacy and safety in (advanced) relapsing- multiple sclerosis
    Zrzavy, T.
    Daniels, E.
    Winkelmann, A.
    Rauschka, H.
    Hecker, M.
    Stuka, N.
    Weber, D.
    Aboulenein-Djamshidian, F.
    Meister, S.
    Leutmezer, F.
    Berger, T.
    Bsteh, G.
    Zettl, U. K.
    Rommer, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 326 - 326
  • [24] Evaluation of the safety, efficacy and retention of mitoxantrone in Cypriot patients with primary progressive multiple sclerosis.
    Kkolou, E.
    Gaglia, E.
    Toufexis, J.
    Pantzaris, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 157 - 157
  • [25] Retrospective study to assess the efficacy and safety of mitoxantrone in multiple sclerosis patients with different therapy courses
    Bonaventura, I.
    Marco, M.
    Romero, S.
    Quintana, S.
    Delgado, T.
    MULTIPLE SCLEROSIS, 2008, 14 : S33 - S33
  • [26] Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients
    Lasek-Bal, Anetta
    Bartoszek, Karina
    Steposz, Arkadiusz
    Puz, Przemyslaw
    Bal, Wieslaw
    Kazibutowska, Zofia
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (10) : 859 - 863
  • [27] Mitoxantrone for multiple sclerosis
    Boneschi, Martinelli F.
    Rovaris, M.
    Capra, R.
    Comi, G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [28] Safety profile of mitoxantrone in a cohort of 802 multiple sclerosis patients
    Edan, G
    Brochet, B
    Brassat, D
    Clanet, M
    Clavelou, P
    Confavreux, C
    Debouverie, M
    Heinzleff, O
    Lebrun, C
    Lubetzki, C
    Pelletier, J
    Madigand, M
    Rumbach, L
    Leray, E
    NEUROLOGY, 2002, 58 (07) : A168 - A168
  • [29] Long-term safety of mitoxantrone therapy for multiple sclerosis
    Mulroy, E.
    Joyce, E.
    Scott, J.
    Melling, J.
    Goggin, C.
    Mahon, N.
    O''Rourke, K. E. T.
    Lynch, T.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S445 - S445
  • [30] Mitoxantrone for multiple sclerosis
    Boneschi, Filippo Martinelli
    Vacchi, Laura
    Rovaris, Marco
    Capra, Ruggero
    Comi, Giancarlo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
12345